Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
10.1073/pnas.0402763101 154
Gastrointestinal effects are particularly common, especially during treatment initiation and dose escalation: Nausea classified as 'very common' (affecting more than 1 in 10 patients) in the SmPC [1] [2] Vomiting 'common' (affecting up to 1 in 10 patients) Diarrhoea 'common' according to the MHRA/EMC SmPC Constipation 'common', likely related to delayed gastric emptying Abdominal pain or discomfort 'common', generally mild to moderate in severity Decreased appetite 'common', which may lead to reduced food intake and weight loss (note that while weight loss can occur with Ozempic, it is not licensed for weight management in the UK) [1] [2] These gastrointestinal symptoms usually diminish over time as the body adapts to the medication
In the same year, there were 50 million obese females and 74 million obese males in the world [6]
(2000) 55 Suppl 2:18
US$ 28.88
US$ 20.46
US$ 28.30
US$ 21.80
US$ 21.53
US$ 27.61
US$ 23.20
